0001209191-23-049031.txt : 20230911 0001209191-23-049031.hdr.sgml : 20230911 20230911193835 ACCESSION NUMBER: 0001209191-23-049031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230909 FILED AS OF DATE: 20230911 DATE AS OF CHANGE: 20230911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Loewy Caroline M CENTRAL INDEX KEY: 0001367451 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39866 FILM NUMBER: 231248781 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc. CENTRAL INDEX KEY: 0001828522 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853306396 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 NORTH CEDROS AVENUE, SUITE B CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: (858) 925-8215 MAIL ADDRESS: STREET 1: 142 NORTH CEDROS AVENUE, SUITE B CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER COMPANY: FORMER CONFORMED NAME: Locust Walk Acquisition Corp. DATE OF NAME CHANGE: 20201015 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-09 0 0001828522 eFFECTOR Therapeutics, Inc. EFTR 0001367451 Loewy Caroline M C/O EFFECTOR THERAPEUTICS, INC. 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 1 0 0 0 0 Stock Option (Right to Buy) 0.646 2023-09-09 4 A 0 40000 0.00 A 2033-09-08 Common Stock 40000 40000 D The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on September 9, 2023, subject to the Reporting Person's continued service with the Issuer through each vesting date. /s/ Michael Byrnes, Attorney-in-Fact for Caroline M. Loewy 2023-09-11